101 related articles for article (PubMed ID: 30481525)
21. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
[TBL] [Abstract][Full Text] [Related]
22. Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.
Pujol CA; Sepúlveda CS; Richmond V; Maier MS; Damonte EB
Arch Virol; 2016 Jul; 161(7):1993-9. PubMed ID: 27101075
[TBL] [Abstract][Full Text] [Related]
23. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
24. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.
Tiwari V; Tarbutton MS; Shukla D
Molecules; 2015 Feb; 20(2):2707-27. PubMed ID: 25665065
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye.
Valyi-Nagy T; Sheth V; Clement C; Tiwari V; Scanlan P; Kavouras JH; Leach L; Guzman-Hartman G; Dermody TS; Shukla D
Curr Eye Res; 2004; 29(4-5):303-9. PubMed ID: 15590476
[TBL] [Abstract][Full Text] [Related]
26. Polyethylene glycol-mediated fusion of herpes simplex type 1 virions with the plasma membrane of cells that support endocytic entry.
Walker EB; Pritchard SM; Cunha CW; Aguilar HC; Nicola AV
Virol J; 2015 Nov; 12():190. PubMed ID: 26573723
[TBL] [Abstract][Full Text] [Related]
27. GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses.
Lee EC; Davis-Poynter N; Nguyen CT; Peters AA; Monteith GR; Strounina E; Popat A; Ross BP
Nanoscale; 2016 Sep; 8(36):16192-6. PubMed ID: 27604476
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
29. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics.
Gangji RN; Sankaranarayanan NV; Elste J; Al-Horani RA; Afosah DK; Joshi R; Tiwari V; Desai UR
ACS Med Chem Lett; 2018 Aug; 9(8):797-802. PubMed ID: 30128070
[TBL] [Abstract][Full Text] [Related]
31. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.
Clementi N; Criscuolo E; Cappelletti F; Quaranta P; Pistello M; Diotti RA; Sautto GA; Tarr AW; Mailland F; Concas D; Burioni R; Clementi M; Mancini N
Antiviral Res; 2017 Jul; 143():48-61. PubMed ID: 28396205
[TBL] [Abstract][Full Text] [Related]
32. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
33. Multiple Roles of the Cytoplasmic Domain of Herpes Simplex Virus 1 Envelope Glycoprotein D in Infected Cells.
Arii J; Shindo K; Koyanagi N; Kato A; Kawaguchi Y
J Virol; 2016 Nov; 90(22):10170-10181. PubMed ID: 27581980
[TBL] [Abstract][Full Text] [Related]
34. B Virus (Macacine herpesvirus 1) Glycoprotein D Is Functional but Dispensable for Virus Entry into Macaque and Human Skin Cells.
Perelygina L; Patrusheva I; Vasireddi M; Brock N; Hilliard J
J Virol; 2015 May; 89(10):5515-24. PubMed ID: 25740986
[TBL] [Abstract][Full Text] [Related]
35. Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1.
Terry-Allison T; Montgomery RI; Warner MS; Geraghty RJ; Spear PG
Virus Res; 2001 Apr; 74(1-2):39-45. PubMed ID: 11226572
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
37. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus in iridocorneal endothelial syndrome.
Hooks JJ; Kupfer C
Arch Ophthalmol; 1995 Oct; 113(10):1226-8. PubMed ID: 7575245
[No Abstract] [Full Text] [Related]
39. Herpes simplex keratitis.
Kaye S; Choudhary A
Prog Retin Eye Res; 2006 Jul; 25(4):355-80. PubMed ID: 16807055
[TBL] [Abstract][Full Text] [Related]
40. Entry of Herpes Simplex Virus 1 into Epidermis and Dermal Fibroblasts Is Independent of the Scavenger Receptor MARCO.
Thier K; Möckel M; Palitzsch K; Döhner K; Sodeik B; Knebel-Mörsdorf D
J Virol; 2018 Aug; 92(15):. PubMed ID: 29769337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
